BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32412912)

  • 1. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
    Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
    Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
    Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
    Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
    Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
    Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
    Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
    Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes as prognostic predictors in endometrial carcinomas.
    Farkas SA; Sorbe BG; Nilsson TK
    Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
    Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
    Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
    Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
    Ma Y; Xi Z
    Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer.
    Piergentili R; Zaami S; Cavaliere AF; Signore F; Scambia G; Mattei A; Marinelli E; Gulia C; Perelli F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms in endometrial cancer.
    Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
    J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
    Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
    Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
    [No Abstract]   [Full Text] [Related]  

  • 18. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Yanokura M; Banno K; Adachi M; Aoki D; Abe K
    Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress of DNA Methylation in Endometrial Cancer.
    Xu T; Ding H; Chen J; Lei J; Zhao M; Ji B; Chen Y; Qin S; Gao Q
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.